Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Combined With Temozolomide in EGFR-High Glioblastoma
NCT06327451Phase 2Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Apr 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in glioblastoma (GBM), sponsored by Tianjin Medical University General Hospital. Started Apr 2024; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT06327451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06327451.